The Rational Design and Development of A Dual Chamber Vaginal/Rectal Microbicide Gel Formulation for HIV Prevention

The DuoGel™ was developed for safe and effective dual chamber administration of antiretroviral drugs to reduce the high incidence of HIV transmission during receptive vaginal and anal intercourse. The DuoGel™s containing IQP-0528, a non-nucleoside reverse transcriptase inhibitor (NNRTI), were formul...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Antiviral Res
Päätekijät: Ham, Anthony S., Nugent, Sean T., Peters, Jennifer J., Katz, David F., Shelter, Cory M., Dezzutti, Charlene S., Boczar, Ashlee D., Buckheit, Karen W., Buckheit, Robert W.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4492852/
https://ncbi.nlm.nih.gov/pubmed/26093158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2015.06.010
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia